BTIG Initiates Coverage On Pulse Biosciences with Buy Rating, Announces Price Target of $70
Benzinga Newsdesk 1 month ago
Analyst RatingsNewsInitiationPrice Target
BTIG analyst Marie Thibault initiates coverage on Pulse Biosciences (NASDAQ:PLSE) with a Buy rating and announces Price Target of $70.
BTIG analyst Marie Thibault initiates coverage on Pulse Biosciences (NASDAQ:PLSE) with a Buy rating and announces Price Target of $70.